This data note examines the characteristics of nursing facilities and the people living in them with data from Nursing Home Compare, a publicly available dataset that provides a snapshot of information on quality of care in each nursing facility, and CASPER (Certification and Survey Provider Enhanced Reports), a dataset that includes detailed metrics collected by…
Are you a self-insured employer looking for ways to reduce healthcare spend? Join us for a webinar on December 11 in which HR executives will share their insights. The post Where Can Self-Insured Employers Look to Find Healthcare Savings? appeared first on MedCity News.
When Cynthia Ruiz turns on her kitchen faucet, she hears a slight squeak before cloudy fluid bursts out of the spout. The water in her Central Valley town of East Orosi is clean enough most of the time to wash dishes, flush toilets, and take showers, but it’s not safe to swallow. Drinking water is…
The Ohio High Value Network is led by Cibolo Health, which has led similar efforts in North Dakota and Minnesota
Bristol Myers Squibb’s new multibillion-dollar partnership in a hot area of cancer research overshadowed many of the announcements at the recent annual meeting of the American Society of Clinical Oncology in Chicago. We covered that news and other developments from the largest cancer conference in the world. The post ASCO 2025 Recap: Rise of the…
The healthcare ecosystem is fixing how quickly decisions get made, without fixing how quickly money actually moves. This isn’t a failure of reform. It’s evidence that reform is working — and revealing where modernization needs to continue. The post The 72-Hour Hurdle: Faster Prior Authorization is Exposing Healthcare’s Broken Billing Cycle appeared first on MedCity…
Orbis Medicines’ Series A round of funding was led by New Enterprise Associates. The startup is developing oral macrocyclic drugs for targets validated by blockbuster biologic medications that must be administered by injection. The post A Startup’s €90M Financing for Oral Peptide Drugs Includes Backing from Eli Lilly appeared first on MedCity News.
Roche’s Gazyva, which first reached the market as a blood cancer drug, has expanded its FDA approval to include treatment of the autoimmune disorder lupus nephritis. The CD20-targeting antibody can now compete against a blockbuster GSK drug that is the standard biologic therapy for the debilitating kidney condition. The post FDA Approval for Roche Cancer…
Cedar Gate Technologies’ Tobin Lassen describes what hospitals chosen for the mandatory model should be focusing on before facing downside risk
To truly drive safety at scale, healthcare organizations will have to look beyond just adverse events and better leverage insights from one of the most valuable, but often underutilized, sources of safety data: near misses. The post From Close Calls to Safer Systems: Rethinking Near Miss Reporting in Healthcare appeared first on MedCity News.